Danaher Corp
NYSE:DHR
Relative Value
The Relative Value of one DHR stock under the Base Case scenario is 274.71 USD. Compared to the current market price of 247.4 USD, Danaher Corp is Undervalued by 10%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
DHR Competitors Multiples
Danaher Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Danaher Corp
NYSE:DHR
|
183.2B USD | 4.2 | 22.7 | 16.5 | 20.4 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 5.2 | 37 | 22.8 | 33.5 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.9T KRW | 15.1 | 65.2 | 34.4 | 49.5 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.4B CHF | 5.6 | 57.2 | 19.6 | 28.8 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.2B USD | 2.8 | 30.3 | 16.5 | 25.6 | ||
US |
Agilent Technologies Inc
NYSE:A
|
41.2B USD | 6.1 | 33.3 | 26.6 | 32 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.1 | 23.9 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 9.1 | 47.1 | 32.7 | 39.6 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.1 | 17.2 | 26.4 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19B EUR | 7 | 74.5 | 32.1 | 52.7 | ||
US |
Illumina Inc
NASDAQ:ILMN
|
18.9B USD | 4.2 | -14.7 | -28.2 | -17.3 |